COVID-19 Knowledge, Attitudes, Practices and Perceived Risk: Cross Sectional Mixed Methods
NCT ID: NCT07021716
Last Updated: 2025-06-15
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
148 participants
OBSERVATIONAL
2020-04-01
2020-12-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Self-compassion for People with Multiple Sclerosis: an Exploratory Feasibility Study
NCT06337903
Examination of a Self-Compassion Course for Healthcare Providers Working With People With Multiple Sclerosis
NCT07097402
Impact of the Modifications of Environmental Exposures and Health Care Access During COVID-19 Lockdown on Multiple Sclerosis
NCT05033782
Adherence to Mediterranean Diet and Cardiovascular Health in Multiple Sclerosis Female Patients: a Case Control Study
NCT05175378
Development and Evaluation of the Self-management Module in Patients With Multiple Sclerosis
NCT05209113
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Theoretical Framework. The knowledge-attitude-behavior (KAB) model considers that knowledge and information gained are fundamental prerequisite for behavioral changes. People are able to gain knowledge and practical skills through education. Accordingly, professionals, laypeople, and patients need to learn and get basic and advanced knowledge, which can lead to the growth of positive beliefs and attitudes that are fortified with the acceptance of healthy behaviors (Liu et al., 2016; Zulkifli et al., 2022). Furthermore, the KAB framework highlights the relationship between knowledge, attitudes and behaviors and their influence on actions (Maleki et al., 2020).
Instruments. The KAP questionnaire consisted of a demographic form, and a KAP questionnaire. The prequestionnaire solicited basic demographic information such as the participant's age, gender, education level, and patients' disease related information. The KAP instrument was adapted from the CDC (CDC; CDC Center for Disease Control; Maike WintersComments to Author 2017) and used with permission. The KAP survey instrument has been used nationally and internationally to explore people's health behaviors and their lifestyle changes (Azlan et al., 2020; CDC; Masoud et al., 2021; Qalati et al., 2023; Zhong et al., 2020). The survey included 50 close-ended questions that took 20-25 minutes to complete. It covered demographics (10 items), COVID-19 knowledge (15 items), attitudes (17 items), and practices (8 items). True/false questions had "I don't know" and "declined to answer" options, with responses categorized as correct or incorrect (Seninde \& Chambers, 2021; Smyth et al., 2006). Open-ended questions were analyzed to assess the participants' perceptions qualitatively.
Perceived risk for contracting COVID-19 was assessed using a 5-point scale (0=no risk at all, 1=a small risk, 2=a moderate risk, 3=a high risk, 4=Don't know). Perceived risk of COVID was assessed as a categorical variable. It was analyzed as dichotomous variable (low risk vs. moderate/high risk) and as 4-categorical variable (low risk, moderate risk, high risk and don't know). Perceived risk was assessed and analyzed in each group, patients with MS, healthcare professionals and lay people.
Data Collection. The population for this study included healthcare professionals (nurses and physicians), patients with MS, and lay people from the northeast region in the USA. It included participants from New York, Connecticut and Massachusetts. A convenience sampling approach was used to enhance recruitment. The participants were recruited via blast emails through health centers, MS centers, and community resources. Data were collected via an online self-reported questionnaire from April 2020 to September 2020. The surveys were completed online via anonymous and confidential software, i.e., a 'Monkey' survey. The inclusion criteria of the study included adult people (≥18 years), consisting of patients with MS, healthcare professionals (nurses and physicians), and adult lay people. The project did not include any exclusion criteria.
Data Analysis. Descriptive analyses were used to characterize the sample. Chi-square and Kruskal Wallis tests assessed associations between demographics, KAPs, and perceived risk. Kruskal Wallis test compared KAP across patients with MS, healthcare professionals, and laypeople. Logistic regression assessed the perceived risk as a dependent dichotomized variable (low and moderate/high risk), immunocompromised state or vaccination hesitancy as independent variables controlling for age, sex, and education. Statistical significance was set at p\<.05. A qualitative thematic analysis was performed and coded on participants' comments by two researchers (AB and JS) to identify key themes reaching data saturation.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patients with multiple sclerosis
Patients with multiple sclerosis answered the KAP survey providing answers to open ended questions analyzed qualitatively.
No Interventions
No Interventions
Healthcare professionals
Healthcare professionals answered the KAP survey providing answers to open ended questions analyzed qualitatively.
No Interventions
No Interventions
Laypeople
Laypeople answered the KAP survey providing answers to open ended questions analyzed qualitatively.
No Interventions
No Interventions
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
No Interventions
No Interventions
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* The inclusion criteria of the study included adult people (≥18 years), consisting of patients with MS, healthcare professionals (nurses and physicians), and adult lay people.
Exclusion Criteria:
* The project did not include any exclusion criteria.
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hunter College of City University of New York
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Aliza Bitton Ben-Zacharia
Assistant Professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hunter College
New York, New York, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
24-08027786
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.